HIGHLIGHTS
- who: Mohsen Sheykhhasan and colleagues from the Research Center for Molecular Medicine, Hamadan University of Medical Sciences, Hamadan, Iran have published the research: FLVCR1-AS1 and FBXL19-AS1: Two Putative lncRNA Candidates in Multiple Human Cancers, in the Journal: (JOURNAL) of 22/Dec/2022
- what: The research showed the role of the FLAVR1-AS1/miR-4731-5p/E2F2 axis as a diagnostic marker of poor outcomes and as a potential target for tumor therapy . In this study, the authors demonstrated further the inhibition by ZNF765 on the transcriptional activity of IGF2BP2, which is shown to . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.